Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

BAX, TMO, SYK - Stock News at NYSE Healthcare Sector by CRWEFinance.com


Baxter International Inc. (NYSE:BAX) increased 0.99% to close at $50.00. BAX traded 2.12 million shares for the day and its earning per share remained $2.62. Baxter International Inc. (Baxter) through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter manufactures products in 27 countries and sells them in more than 100 countries. The Company operates in three segments: BioScience, Medication Delivery and Renal.

Thermo Fisher Scientific Inc. (NYSE:TMO) increased 2.11% to close at $51.76. TMO traded 1.93 million shares for the day and its earning per share remained $2.44. Thermo Fisher Scientific Inc. (Thermo Fisher) is engaged in serving science. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through two segments: analytical technologies and laboratory products and services. Analytical technologies segment includes pharmaceutical, biotechnology, academic, government and other research and industrial markets.

Stryker Corporation (NYSE:SYK) increased 0.83% to close at $51.30. SYK traded 1.30 million shares for the day and its earning per share remained $3.22. Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, spinal and craniomaxillofacial; surgical equipment and surgical navigation systems, endoscopic and communications systems; patient handling and emergency medical equipment, as well as other medical device products used in a variety of medical specialties. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip and knee), trauma, and spinal implant systems.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.



Disclosure: No positions